e-learning
resources
Amsterdam 2011
Wednesday, 28.09.2011
Tuberculosis in special populations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Managing tuberculosis in chronic kidney disease: An evaluation of patient treatment regimens
A. Riding, P. Palchaudhuri, P. Begum, M. Ostermann, H. Milburn (London, United Kingdom)
Source:
Annual Congress 2011 - Tuberculosis in special populations
Session:
Tuberculosis in special populations
Session type:
Oral Presentation
Number:
4899
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Riding, P. Palchaudhuri, P. Begum, M. Ostermann, H. Milburn (London, United Kingdom). Managing tuberculosis in chronic kidney disease: An evaluation of patient treatment regimens. Eur Respir J 2011; 38: Suppl. 55, 4899
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Efficiency of treatment regimens for chronic tuberculosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 519s
Year: 2003
Extrapulmonary tuberculosis in patients with chronic kidney disease receiving renal replacement therapy
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays
Source: Eur Respir J 2007; 30: Suppl. 51, 752s
Year: 2007
Efficacy and safety of modified anti-tubercular treatment(ATT) regimens in treatment of tuberculosis(TB) in patients with underlying chronic liver disease(CLD)
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016
Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease
Source: Eur Respir J 2006; 28: Suppl. 50, 131s
Year: 2006
Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Chronic interstitial lung disease in children: diagnosis and treatment
Source: International Congress 2016 – PG6 Lung fibrosis and sarcoidosis
Year: 2016
Comparison of two physiotherapy treatments in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021
Double impact: Difficulties in treating patients with liver diseases from tuberculosis
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011
Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 243-244
Year: 2002
Transition from treatment to palliation in chronic lung disease
Source: Annual Congress 2006 - PG10 - Preparation and palliation for end-of-life in chronic respiratory disease
Year: 2006
Integrated disease management improves long-term quality of life in primary care COPD patients
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007
Efficacy of home-based pulmonary rehabilitation program for the patients with chronic lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 164s
Year: 2003
A development study of pulmonary rehabilitation for patients with chronic lung disease in Uganda
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Rehabilitation in primary care: can we do it?
Source: Annual Congress 2007 - Primary care: who? Where? How? Exercise testing and pulmonary rehabilitation
Year: 2007
Strategy for early diagnosis and intervention in chronic respiratory disease
Source: Virtual Congress 2020 – Chinese programme 2020: Part I
Year: 2020
Time to move from prognostication to diagnosis and treatment of heart disease in acute exacerbation of COPD
Source: Eur Respir J, 49 (6) 1700912; 10.1183/13993003.00912-2017
Year: 2017
Does regular physiotherapy prevent LRTIs in patients with chronic lung disease?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009
Side-effects of antituberculosis drug treatment in patients with chronic renal failure
Source: Eur Respir J 2002; 20: 440-443
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept